ArticleACS omega2025
Visible-Light-Driven Photoactivity of Copper/PVA Composite Films against Murine Coronavirus.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Copper Complexes: Emerging Micro- and Nanosystems for Dermatological Treatment.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In light of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic in 2019, the global scientific community has focused their research on developing virucidal materials to mitigate the spread of viruses including self-disinfecting surfaces capable of inactivating viruses that are in contact with the material. Copper stands out in this context due to its intrinsic ability to disrupt viral structures and inhibit replication mechanisms, making cooper-based materials a powerful tool. Furthermore, copper absorbs light in the visible region, a property that has not been fully studied or reported in the literature considering its photoactivity on viruses. To fill this gap, in the present study, composite films containing 2% w/v of copper micro- and nanoparticles and copper oxide (I) microparticles in poly-(vinyl alcohol) (PVA) were synthesized by drop-casting. The films were evaluated against enveloped murine hepatitis virus type 3 (MHV-3) under dark and white light illumination. Using the L929 mouse fibroblast cell line, only the film with copper microparticles showed no cytopathic effect under illumination, indicating virucidal photoactivity. By performing the integrated cell culture and reverse transcription quantitative PCR (ICC-RT-qPCR) assay, it was found that the film promoted a 43.1% reduction of viral load when illuminated, while in the dark, the reduction was lower than 7%. Thus, it was possible to obtain photoactive composite films with relatively low-cost copper microparticles by a conventional deposition technique. These promising results contribute to advancing research on visible-light-driven materials and photofunctional surfaces that use solar energy as a power source, offering innovative solutions to combat the spread of pathogens.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.